These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 34624023)
21. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. de Lusignan S; Dorward J; Correa A; Jones N; Akinyemi O; Amirthalingam G; Andrews N; Byford R; Dabrera G; Elliot A; Ellis J; Ferreira F; Lopez Bernal J; Okusi C; Ramsay M; Sherlock J; Smith G; Williams J; Howsam G; Zambon M; Joy M; Hobbs FDR Lancet Infect Dis; 2020 Sep; 20(9):1034-1042. PubMed ID: 32422204 [TBL] [Abstract][Full Text] [Related]
23. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970 [TBL] [Abstract][Full Text] [Related]
24. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2. Hernandez-Romieu AC; Carton TW; Saydah S; Azziz-Baumgartner E; Boehmer TK; Garret NY; Bailey LC; Cowell LG; Draper C; Mayer KH; Nagavedu K; Puro JE; Rasmussen SA; Trick WE; Wanga V; Chevinsky JR; Jackson BR; Goodman AB; Cope JR; Gundlapalli AV; Block JP JAMA Netw Open; 2022 Feb; 5(2):e2147053. PubMed ID: 35119459 [TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 and pregnancy outcomes under universal and non-universal testing in Sweden: register-based nationwide cohort study. Stephansson O; Pasternak B; Ahlberg M; Hervius Askling H; Aronsson B; Appelqvist E; Jonsson J; Sengpiel V; Söderling J; Norman M; Ludvigsson JF; Neovius M BJOG; 2022 Jan; 129(2):282-290. PubMed ID: 34706148 [TBL] [Abstract][Full Text] [Related]
27. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021. Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626 [TBL] [Abstract][Full Text] [Related]
28. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766 [TBL] [Abstract][Full Text] [Related]
29. The use of health care during the SARS-CoV-2 pandemic: repeated cross-sectional survey of the adult Swiss general population. Giezendanner S; Fischer R; Diaz Hernandez L; Zeller A BMC Public Health; 2021 May; 21(1):853. PubMed ID: 33941109 [TBL] [Abstract][Full Text] [Related]
31. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic. Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813 [TBL] [Abstract][Full Text] [Related]
32. Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study. McNaughton CD; Austin PC; Sivaswamy A; Fang J; Abdel-Qadir H; Daneman N; Udell JA; Wodchis WP; Mostarac I; Lee DS; Atzema CL CMAJ; 2022 Oct; 194(40):E1368-E1376. PubMed ID: 36252983 [TBL] [Abstract][Full Text] [Related]
33. Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study. Telle K; Jørgensen SB; Hart R; Greve-Isdahl M; Kacelnik O Eur J Epidemiol; 2021 Jul; 36(7):741-748. PubMed ID: 34036466 [TBL] [Abstract][Full Text] [Related]
34. Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021. Starrfelt J; Danielsen AS; Buanes EA; Juvet LK; Lyngstad TM; Rø GØI; Veneti L; Watle SV; Meijerink H BMC Med; 2022 Sep; 20(1):278. PubMed ID: 36050718 [TBL] [Abstract][Full Text] [Related]
35. Migrant background and the impact of the COVID-19 pandemic on mental healthcare consultations among children and adolescents in Norway: a nationwide registry study. Elgersma IH; Hart RK; Straiton ML; Hauge LJ; Reneflot A BMC Health Serv Res; 2023 Jun; 23(1):718. PubMed ID: 37391771 [TBL] [Abstract][Full Text] [Related]
36. Pandemic trends in health care use: From the hospital bed to self-care with COVID-19. Methi F; Hernæs KH; Skyrud KD; Magnusson K PLoS One; 2022; 17(3):e0265812. PubMed ID: 35320323 [TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 infection in pregnancy during the first wave of COVID-19 in the Netherlands: a prospective nationwide population-based cohort study (NethOSS). Overtoom EM; Rosman AN; Zwart JJ; Vogelvang TE; Schaap TP; van den Akker T; Bloemenkamp K BJOG; 2022 Jan; 129(1):91-100. PubMed ID: 34494694 [TBL] [Abstract][Full Text] [Related]
38. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A; JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385 [TBL] [Abstract][Full Text] [Related]
39. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lund LC; Hallas J; Nielsen H; Koch A; Mogensen SH; Brun NC; Christiansen CF; Thomsen RW; Pottegård A Lancet Infect Dis; 2021 Oct; 21(10):1373-1382. PubMed ID: 33984263 [TBL] [Abstract][Full Text] [Related]
40. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A; Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]